1st Quarter - Report
ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Re-authorization of the Pandemic and All-Hazards Preparedness Act FDA regulatory issues Issues related to priority Review Voucher programs Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | — |
| LAWRENCE SPIVEY | — |
Budget/Appropriations BUD
FY2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Department of Defense appropriations for medical countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | — |
| LAWRENCE SPIVEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.